A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
for Primary Generalized Tonic-Clonic Seizures
51 locations incl. Mobile
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All·Age: 12+
Code: NCT05667142·Phase 3·Recruiting·Listed Dec 2022